butabarbital decreases consequences of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Coadministration of CYP3A4 inducers may possibly decrease sufentanil levels and efficacy, probably precipitating withdrawal syndrome in individuals that have made Actual physical dependence to sufentanil. Di